Comparative effectiveness research and measuring the level of pharmaceutical innovation in the EU. (January 2012)

• Record Type: Journal Article
• Authors: Annemans, Lieven; Cleemput, Irina; Hulstaert, Frank; Simoens, Steven
• Is Part Of: Journal of comparative effectiveness research. Volume 1:Number 1(2012)
• Page Start: 19
• Page End: 29
• Publication Date: 2012-01
• Subjects: comparative effectiveness -- EU -- level of innovation -- medical need -- orphan medicines -- personalized medicine -- pharmaceutical innovation; Medical care -- Research -- Periodicals; Medical care -- Research -- Evaluation -- Periodicals; Medical care -- Decision making -- Periodicals; Evidence-based medicine -- Periodicals; Medicine, Comparative -- Periodicals; 362.1072
• DOI: 10.2217/cer.11.1
• Languages: English
• ISSNs: 2042-6305

Abstract

Over the past 50 years, medicines have made a huge contribution to improving the health status of populations. However, the level of pharmaceutical innovation varies widely, ranging from breakthrough treatments for life-threatening diseases to minor modifications of medicines that have been on the market for some time. Once innovative medicines approach the market, a system of measuring the level of innovation should be established. This perspective describes the current situation, the challenges and initiatives, and formulates recommendations for a coordinated EU action to measure the level of pharmaceutical innovation. In our opinion, comparative effectiveness research needs to play a central role in measuring the level of pharmaceutical innovation.